HTX-011, a proprietary, extended-release combination of bupivacaine and meloxicam, reduced pain intensity and opioid consumption for 96 hours following abdominoplasty

Authors
Category Primary study
ConferenceRegional Anesthesia and Pain Medicine
Year 2017
This article has no abstract
Epistemonikos ID: 36d4530a2d277945f194808647c377d5edf2b6bd
First added on: Apr 29, 2026